Pyrazine derivatives as sodium channel modulators for the treatment of pain

Details for Australian Patent Application No. 2006310215 (hide)

Owner Pfizer Limited

Inventors Kemp, Mark Ian; Glossop, Melanie Susanne; Gibson, Karl Richard; Poinsard, Cedric

Agent Allens Arthur Robinson

Pub. Number AU-A-2006310215

PCT Pub. Number WO2007/052123

Priority 60/733,662 04.11.05 US

Filing date 23 October 2006

Wipo publication date 10 May 2007

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/497 (2006.01)

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

15 May 2008 PCT application entered the National Phase

  PCT publication WO2007/052123 Priority application(s): WO2007/052123

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310217-Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent

2006310214-Method of producing an impact-resistant thermoplastic resin